RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Craniocerebral Trauma
Accession: DOID:9007621
browse the term
Definition: Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.
Synonyms: exact_synonym: Craniocerebral Injuries; Craniocerebral Injury; Craniocerebral Traumas; Crushing Skull Injuries; Crushing Skull Injury; Forehead Trauma; Forehead Traumas; Frontal Region Trauma; Frontal Region Traumas; Head Injuries; Head Injury; Head Trauma; Head Traumas; Minor Head Injuries; Minor Head Injury; Multiple Head Injuries; Multiple Head Injury; Occipital Region Trauma; Occipital Region Traumas; Occipital Trauma; Occipital Traumas; Open Head Injuries; Open Head Injury; Parietal Region Trauma; Parietal Region Traumas; Superficial Head Injuries; Superficial Head Injury; Temporal Region Trauma; Temporal Region Traumas
primary_id: MESH:D006259 ; RDO:0005059
xref: EFO:0009505
GViewer not supported for the selected species.
G
ADNP
activity dependent neuroprotector homeobox
ISO
RGD
PMID:11123362
RGD:2312784
NCBI chr 2:13,037,446...13,080,287
Ensembl chr 2:13,039,866...13,081,161
G
IL1A
interleukin 1 alpha
ISO
protein:increased expression:microglial cell
RGD
PMID:7830934
RGD:10045949
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
G
POSTN
periostin
ISO
RGD
PMID:17878602
RGD:10041014
NCBI chr 3:16,060,013...16,095,867
Ensembl chr 3:16,059,965...16,095,791
G
SERPINC1
serpin family C member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8810955
NCBI chr25:55,271,823...55,289,855
G
EPO
erythropoietin
treatment
ISO
RGD
PMID:23415790
RGD:10401075
NCBI chr28:12,487,222...12,491,986
Ensembl chr28:12,489,766...12,491,908
G
F7
coagulation factor VII
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12503044
NCBI chr 3:91,109,864...91,122,707
Ensembl chr 3:91,110,380...91,123,327
G
KCNN4
potassium calcium-activated channel subfamily N member 4
treatment
ISO
RGD
PMID:15379997
RGD:329969897
NCBI chr 6:37,289,088...37,316,850
G
CFL1
cofilin 1
treatment
ISO
RGD
PMID:25708984
RGD:12738361
NCBI chr 1:8,408,560...8,410,564
G
DRD2
dopamine receptor D2
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr 1:104,774,632...104,843,417
Ensembl chr 1:104,774,180...104,842,736
G
DRD3
dopamine receptor D3
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr22:66,683,987...66,737,645
Ensembl chr22:66,691,177...66,736,690
G
DRD4
dopamine receptor D4
ISO
RGD
PMID:26448536
RGD:13506960
NCBI chr 1:454,018...459,582
G
IL6
interleukin 6
treatment
ISO
RGD
PMID:27113205
RGD:11062140
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
G
C3
complement C3
ameliorates
ISO
RGD
PMID:31654641
RGD:408418727
NCBI chr 6:6,250,422...6,289,264
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:28140659
RGD:13782305
NCBI chr 7:130,589,592...130,610,845
Ensembl chr 7:130,591,166...130,610,899
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:28140659
RGD:13782305
NCBI chr10:86,888,654...86,944,159
Ensembl chr10:86,916,527...86,943,829
G
IL1B
interleukin 1 beta
treatment
ISO
RGD
PMID:31654641
RGD:408418727
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
PYCARD
PYD and CARD domain containing
treatment
ISO
RGD
PMID:19401709
RGD:5491174
NCBI chr 5:27,892,332...27,894,386
Ensembl chr 5:27,889,230...27,893,697
G
TNF
tumor necrosis factor
treatment
ISO
RGD
PMID:31654641
RGD:408418727
G
ABCC8
ATP binding cassette subfamily C member 8
treatment
ISO
RGD
PMID:21107131
RGD:12791995
NCBI chr 1:47,494,861...47,578,818
Ensembl chr 1:47,494,959...47,578,882
G
ACAN
aggrecan
ISO
mRNA:increased expression:fascia dentata (rat)
RGD
PMID:18511192
RGD:2315807
NCBI chr29:7,345,350...7,416,951
G
ACTR2
actin related protein 2
ISO
mRNA, protein:decreased expression:hippocampus (rat)
RGD
PMID:22120305
RGD:11530046
NCBI chr14:41,740,432...41,780,045
Ensembl chr14:41,739,968...41,779,964
G
ADCYAP1
adenylate cyclase activating polypeptide 1
ISO
RGD
PMID:16689670
RGD:2325298
NCBI chr18:60,259,479...60,267,302
G
ADRA1A
adrenoceptor alpha 1A
ISO
mRNA:increased expression:frontal cortex
RGD
PMID:20974230
RGD:5688366
NCBI chr 8:24,884,187...24,985,824
Ensembl chr 8:24,885,741...24,983,125
G
AGER
advanced glycosylation end-product specific receptor
ISO
protein:increased expression:brain (rat)
RGD
PMID:22491548 PMID:22915134 PMID:24859607
RGD:7245513 RGD:7245557 RGD:8696001
NCBI chr17:39,847,343...39,851,288
Ensembl chr17:39,847,759...39,851,127
G
AIF1
allograft inflammatory factor 1
ISO
protein:increased expression:cerebral cortex (rat)
RGD
PMID:19520144
RGD:2313020
G
AIFM1
apoptosis inducing factor mitochondria associated 1
ISO
protein:increased expression:nucleus:
RGD
PMID:12091479
RGD:10053567
NCBI chr X:105,383,408...105,419,146
Ensembl chr X:105,382,693...105,419,095
G
AKT1
AKT serine/threonine kinase 1
ISO
protein:increased phosphorylation:brain, neuron
RGD
PMID:16234845
RGD:5509090
NCBI chr24:82,704,087...82,730,711
Ensembl chr24:82,704,068...82,727,698
G
ALB
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7909931 PMID:17188501
NCBI chr 7:21,872,036...21,890,095
Ensembl chr 7:21,876,132...21,891,407
G
AMBP
alpha-1-microglobulin/bikunin precursor
ISO
protein:increased expression:urine
RGD
PMID:14592616
RGD:6904155
NCBI chr12:25,508,516...25,526,821
Ensembl chr12:25,508,682...25,527,016
G
ANK3
ankyrin 3
ISO
RGD
PMID:20557305
RGD:6767288
NCBI chr 9:70,549,665...71,253,928
Ensembl chr 9:70,893,260...71,254,245
G
ANP32A
acidic nuclear phosphoprotein 32 family member A
ISO
RGD
PMID:24385964
RGD:10401136
NCBI chr26:14,650,600...14,691,108
Ensembl chr26:14,653,745...14,691,492
G
APAF1
apoptotic peptidase activating factor 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:11567033
RGD:2325751
NCBI chr11:93,942,137...94,024,728
Ensembl chr11:93,942,103...94,024,457
G
APBB1
amyloid beta precursor protein binding family B member 1
ISO
mRNA:increased expression:brain
RGD
PMID:12707777
RGD:2301208
NCBI chr 1:58,407,323...58,431,551
Ensembl chr 1:58,421,847...58,431,144
G
APEX1
apurinic/apyrimidinic endodeoxyribonuclease 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11447995
NCBI chr29:20,978,878...20,981,393
G
APOD
apolipoprotein D
ISO
mRNA, protein:increased expression:cerebral cortex, glia cell, neuron
RGD
PMID:10501208
RGD:2311202
NCBI chr15:89,612,210...89,624,038
Ensembl chr15:89,612,040...89,624,012
G
APP
amyloid beta precursor protein
ISO
protein:increased expression:hippocampus
RGD
PMID:16300758
RGD:10054281
NCBI chr 2:66,037,224...66,320,860
Ensembl chr 2:66,037,261...66,321,306
G
AQP4
aquaporin 4
ISO
protein:increased expression:cerebral cortex
RGD
PMID:21083433 PMID:21488209
RGD:5148014 RGD:5148034
NCBI chr18:53,729,143...53,742,916
Ensembl chr18:53,729,186...53,743,156
G
ASIC1
acid sensing ion channel subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21307247
NCBI chr11:46,286,665...46,313,016
Ensembl chr11:46,287,787...46,314,177
G
ASTN1
astrotactin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14499481
NCBI chr25:52,110,983...52,416,743
Ensembl chr25:52,110,880...52,413,554
G
ATG12
autophagy related 12
ISO
protein:altered localization:brain
RGD
PMID:18059433
RGD:2301217
NCBI chr23:19,073,545...19,087,603
Ensembl chr23:19,072,401...19,087,625
G
ATP5PD
ATP synthase peripheral stalk subunit d
treatment
ISO
RGD
PMID:26813465
RGD:13800884
NCBI chr16:46,625,512...46,630,613
G
AVPR1A
arginine vasopressin receptor 1A
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:17244947
RGD:2300372
NCBI chr11:59,074,699...59,079,710
Ensembl chr11:59,071,202...59,079,596
G
BAD
BCL2 associated agonist of cell death
ISO
mRNA, protein:increased expression:cerebral cortex
RGD
PMID:15941375
RGD:2292694
NCBI chr 1:9,949,717...9,964,433
Ensembl chr 1:9,949,762...9,964,432
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:20888848
RGD:10054247
NCBI chr 6:42,186,028...42,193,105
G
BCAT1
branched chain amino acid transaminase 1
ISO
Protein:increased expression:neurons
RGD
PMID:10686349
RGD:631308
NCBI chr11:24,578,760...24,709,541
Ensembl chr11:24,579,487...24,709,132
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:18093155 PMID:20888848
RGD:10054247 RGD:2293059
NCBI chr18:16,440,560...16,643,187
Ensembl chr18:16,441,733...16,637,895
G
BDNF
brain derived neurotrophic factor
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:15500971 PMID:20544832 PMID:21269288
RGD:4891136
NCBI chr 1:37,386,825...37,451,380
Ensembl chr 1:37,449,593...37,450,336
G
BECN1
beclin 1
ISO
protein:increased expression:neuron, astrocyte CTD Direct Evidence: therapeutic protein:increased expression:hippocampus protein:increased expression:brain
RGD CTD
PMID:16874043 PMID:18500386 PMID:24221859 PMID:34929507
RGD:11558018 RGD:6483098 RGD:6483314
NCBI chr16:63,469,187...63,482,627
Ensembl chr16:63,469,192...63,485,322
G
BIRC5
baculoviral IAP repeat containing 5
ISO
mRNA, protein:increased expression:brain, astrocyte, neuron
RGD
PMID:15453988
RGD:2293136
NCBI chr16:70,226,824...70,237,000
G
BMP6
bone morphogenetic protein 6
ISO
protein:increased expression:brain, astrocyte, neuron
RGD
PMID:16388909
RGD:2289020
NCBI chr17:64,279,243...64,436,356
Ensembl chr17:64,280,609...64,435,382
G
BMPR2
bone morphogenetic protein receptor type 2
ISO
mRNA:increased expression:dentate gyrus, neuron
RGD
PMID:9080432
RGD:5129488
NCBI chr10:88,103,442...88,302,578
Ensembl chr10:88,106,072...88,303,734
G
BYSL
bystin like
ISO
mRNA, protein:increased expression:substantia nigra, striatum (rat)
RGD
PMID:15305856
RGD:2316201
NCBI chr17:30,230,001...30,241,684
Ensembl chr17:30,230,337...30,241,417
G
C1QA
complement C1q A chain
ISO
RGD
PMID:23808389
RGD:10054313
NCBI chr20:110,024,847...110,027,868
G
C3
complement C3
ISO
RGD
PMID:23808389
RGD:10054313
NCBI chr 6:6,250,422...6,289,264
G
CASK
calcium/calmodulin dependent serine protein kinase
ISO
RGD
PMID:25089700
RGD:11576302
NCBI chr X:38,704,623...39,121,309
G
CASP1
caspase 1
ISO
mRNA, protein:increased expression:brain
RGD
PMID:17188500
RGD:2315917
NCBI chr 1:96,389,697...96,400,610
Ensembl chr 1:96,389,657...96,400,849
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:20888848
RGD:10054247
NCBI chr 7:130,589,592...130,610,845
Ensembl chr 7:130,591,166...130,610,899
G
CASP8
caspase 8
ISO
protein:altered localization
RGD
PMID:15590916
RGD:1624191
NCBI chr10:86,888,654...86,944,159
Ensembl chr10:86,916,527...86,943,829
G
CAST
calpastatin
severity
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:15307896
RGD:5509821
NCBI chr 4:90,496,867...90,607,019
Ensembl chr 4:90,497,754...90,605,481
G
CCL2
C-C motif chemokine ligand 2
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:brain, neuron
CTD RGD
PMID:11113322 PMID:19210118 PMID:21549006
RGD:2306999 RGD:9587789
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
G
CCL20
C-C motif chemokine ligand 20
treatment
ISO
RGD
PMID:22040257
RGD:7483630
NCBI chr10:113,815,099...113,836,562
Ensembl chr10:113,832,573...113,835,736
G
CCR5
C-C motif chemokine receptor 5
ISO
mRNA:increased expression:hippocampus
RGD
PMID:24344922
RGD:8552265
NCBI chr22:7,803,794...7,818,112
G
CD14
CD14 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr23:43,264,917...43,266,825
Ensembl chr23:43,264,336...43,266,993
G
CD40
CD40 molecule
treatment
ISO
RGD
PMID:23924471
RGD:7248749
NCBI chr 2:17,753,713...17,765,134
Ensembl chr 2:17,753,394...17,764,566
G
CD40LG
CD40 ligand
treatment
ISO
RGD
PMID:11755016 PMID:25972624
RGD:11344972 RGD:8547803
NCBI chr X:111,655,301...111,667,602
Ensembl chr X:111,655,397...111,666,639
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
protein:increased expression:nucleus:
RGD
PMID:9914434
RGD:8662346
NCBI chr17:35,445,668...35,454,334
Ensembl chr17:35,445,223...35,454,342
G
CDKN1B
cyclin dependent kinase inhibitor 1B
ISO
protein:decreased expression:cerebral cortex
RGD
PMID:21728064
RGD:10045359
NCBI chr11:12,612,064...12,617,228
Ensembl chr11:12,612,079...12,617,531
G
CEBPA
CCAAT enhancer binding protein alpha
ISO
mRNA, protein:increased expression:cerebral cortex (mouse)
RGD
PMID:19833158
RGD:10401206
NCBI chr 6:28,342,506...28,345,759
Ensembl chr 6:28,343,907...28,344,977
G
CEBPB
CCAAT enhancer binding protein beta
ISO
mRNA, protein:increased expression:cerebral cortex (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19833158 PMID:21549006
RGD:10401206
NCBI chr 2:13,780,538...13,782,639
Ensembl chr 2:13,781,160...13,782,194
G
CFB
complement factor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17474994
Ensembl chr17:40,069,909...40,094,207
G
CHRM2
cholinergic receptor muscarinic 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr21:105,574,879...105,730,265
Ensembl chr21:105,726,175...105,727,575
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr26:50,554,143...50,686,847
Ensembl chr26:50,551,829...50,686,803
G
CLEC4E
C-type lectin domain family 4 member E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr11:8,315,888...8,322,240
Ensembl chr11:8,316,049...8,321,274
G
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
protein:increased expression:hippocampus
RGD
PMID:20215974
RGD:6483336
NCBI chr16:64,288,583...64,296,940
Ensembl chr16:64,289,828...64,296,922
G
COMT
catechol-O-methyltransferase
ISO
protein:increased expression:hippocampus
RGD
PMID:17240060
RGD:2289740
NCBI chr19:5,775,829...5,803,260
Ensembl chr19:5,773,225...5,785,422
G
CRP
C-reactive protein
disease_progression
ISO
RGD
PMID:24456846
RGD:9585646
NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
G
CSF2
colony stimulating factor 2
disease_progression
ISO
RGD
PMID:21515263
RGD:5686795
NCBI chr23:34,906,987...34,911,252
Ensembl chr23:34,908,911...34,911,140
G
CSF3
colony stimulating factor 3
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21549006 PMID:24239694
RGD:11039431
NCBI chr16:66,162,814...66,166,192
Ensembl chr16:66,163,681...66,165,172
G
CSPG4
chondroitin sulfate proteoglycan 4
ISO
protein:altered expression:cerebral cortex
RGD
PMID:19473238
RGD:5686860
NCBI chr26:7,735,972...7,761,355
Ensembl chr26:7,694,014...7,761,342
G
CUL5
cullin 5
ISO
mRNA, protein:decreased expression:cerebral cortex, hippocampus
RGD
PMID:17010517
RGD:2301432
NCBI chr 1:99,432,034...99,538,296
Ensembl chr 1:99,432,706...99,534,888
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
mRNA:increased expression:choroid plexus, cerebral cortex
RGD
PMID:19471279
RGD:5135009
NCBI chr 7:22,327,041...22,329,405
Ensembl chr 7:22,569,355...22,569,900 Ensembl chr 7:22,569,355...22,569,900
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
G
CYP11A1
cytochrome P450 family 11 subfamily A member 1
ISO
mRNA:increased expression:hindbrain
RGD
PMID:16329132
RGD:1599699
NCBI chr26:9,122,008...9,151,844
G
DAB2
DAB adaptor protein 2
ISO
RGD
PMID:15774263
RGD:7243841
NCBI chr 4:38,171,320...38,224,275
Ensembl chr 4:38,173,026...38,224,231
G
DNMT1
DNA methyltransferase 1
ISO
RGD
PMID:19429151
RGD:9588608
NCBI chr 6:9,199,006...9,263,890
Ensembl chr 6:9,199,003...9,263,607
G
DPYSL2
dihydropyrimidinase like 2
ISO
protein:increased degradation:cerebral cortex, hippocampus
RGD
PMID:17402852
RGD:2303056
NCBI chr 8:24,625,961...24,772,047
Ensembl chr 8:24,690,856...24,772,087
G
DRD2
dopamine receptor D2
ISO
RGD
PMID:18509630
RGD:2311580
NCBI chr 1:104,774,632...104,843,417
Ensembl chr 1:104,774,180...104,842,736
G
DUSP5
dual specificity phosphatase 5
ISO
mRNA:increased expression:cerebral cortex
RGD
PMID:12503083
RGD:2317873
NCBI chr 9:103,435,015...103,449,100
Ensembl chr 9:103,435,343...103,449,171
G
EIF2S1
eukaryotic translation initiation factor 2 subunit alpha
ISO
RGD
PMID:11526986
RGD:10395358
NCBI chr24:44,599,017...44,623,723
Ensembl chr24:44,598,287...44,623,298
G
ENO2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34533065
NCBI chr11:6,945,243...6,954,959
Ensembl chr11:6,945,413...6,957,304
G
EPAS1
endothelial PAS domain protein 1
treatment
ISO
RGD
PMID:22960363
RGD:10395371
NCBI chr14:60,823,110...60,912,804
Ensembl chr14:60,822,815...60,912,785
G
EPHA4
EPH receptor A4
ISO
protein:increased expression, increased activity:astrocyte
RGD
PMID:22318127
RGD:5688763
NCBI chr10:107,344,442...107,501,375
Ensembl chr10:107,352,530...107,499,788
G
EPHX2
epoxide hydrolase 2
ISO
RGD
PMID:21075124
RGD:5688356
NCBI chr 8:25,603,668...25,659,232
Ensembl chr 8:25,603,735...25,659,345
G
EPO
erythropoietin
treatment
ISO
CTD Direct Evidence: therapeutic mRNA:increased expression:brain:
RGD CTD
PMID:18093155 PMID:20833152 PMID:23063952
RGD:10401061 RGD:2293059
NCBI chr28:12,487,222...12,491,986
Ensembl chr28:12,489,766...12,491,908
G
EPOR
erythropoietin receptor
ISO
mRNA:increased expression:brain:
RGD
PMID:18093155
RGD:2293059
NCBI chr 6:10,313,382...10,320,196
Ensembl chr 6:10,313,775...10,320,066
G
FGF2
fibroblast growth factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21269288
NCBI chr 7:70,089,394...70,157,423
G
FMR1
Fragile X messenger ribonucleoprotein 1
ISO
protein:altered localization:hippocampus (rat)
RGD
PMID:16510718
RGD:11667962
NCBI chr X:122,635,383...122,674,298
Ensembl chr X:122,635,439...122,674,355
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9630518
NCBI chr24:52,497,465...52,501,161
Ensembl chr24:52,497,521...52,501,514
G
FOXP1
forkhead box P1
treatment
ISO
RGD
PMID:26842647
RGD:11561903
NCBI chr22:31,907,941...32,538,294
Ensembl chr22:31,912,460...32,154,502
G
G6PD
glucose-6-phosphate dehydrogenase
ISO
protein:decreased expression:hippocampus
RGD
PMID:18501200
RGD:2307353
NCBI chr X:128,768,028...128,788,366
Ensembl chr X:128,770,268...128,786,961
G
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr26:55,319,667...55,543,116
Ensembl chr26:55,471,907...55,538,855
G
GABRG3
gamma-aminobutyric acid type A receptor subunit gamma3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr26:54,570,497...55,126,712
G
GDNF
glial cell derived neurotrophic factor
ISO
mRNA:increased expression:brain
RGD
PMID:18501516
RGD:2324932
NCBI chr 4:36,662,033...36,691,761
Ensembl chr 4:36,665,009...36,684,257
G
GJA1
gap junction protein alpha 1
treatment
ISO
RGD
PMID:23485053
RGD:8662424
NCBI chr13:52,397,291...52,410,341
Ensembl chr13:52,396,109...52,410,339
G
GJA5
gap junction protein alpha 5
ISO
protein:increased expression:cerebral artery
RGD
PMID:21895483
RGD:7207391
G
GPX1
glutathione peroxidase 1
ISO
mRNA:decreased expression:hippocampus, neuron
RGD
PMID:15791111
RGD:2306624
NCBI chr22:10,754,976...10,756,617
G
GRM8
glutamate metabotropic receptor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr21:95,264,905...96,060,822
Ensembl chr21:95,264,765...96,050,554
G
GSK3B
glycogen synthase kinase 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22643085 PMID:24675465
RGD:10045646
NCBI chr22:60,732,449...61,002,735
Ensembl chr22:60,733,465...60,997,239
G
GSN
gelsolin
ISO
RGD
PMID:14588109
RGD:1599864
NCBI chr12:18,253,079...18,317,285
Ensembl chr12:18,253,324...18,285,938
G
HCN1
hyperpolarization activated cyclic nucleotide gated potassium channel 1
ISO
mRNA,protein:decreased expression:hippocampus:
RGD
PMID:11726545
RGD:9686434
NCBI chr 4:44,029,173...44,443,669
G
HMGB1
high mobility group box 1
treatment
ISO
RGD
PMID:22915134
RGD:7245513
NCBI chr 3:9,353,333...9,357,765
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:18562561
RGD:5508455
NCBI chr 4:69,664,784...69,690,343
Ensembl chr 4:69,665,417...69,688,686
G
HMOX1
heme oxygenase 1
ISO
RGD
PMID:23470432
RGD:10755702
NCBI chr19:18,144,466...18,157,944
Ensembl chr19:18,144,545...18,157,971
G
HSPA4
heat shock protein family A (Hsp70) member 4
ISO
protein:increased expression:cerebral white matter (rat)
RGD
PMID:22067617
RGD:5688785
NCBI chr23:35,862,817...35,917,490
Ensembl chr23:35,862,814...35,918,287
G
HSPB1
heat shock protein family B (small) member 1
ISO
RGD
PMID:11746764
RGD:6480530
NCBI chr28:10,442,530...10,443,804
Ensembl chr28:10,442,398...10,443,855
G
HTR7
5-hydroxytryptamine receptor 7
ISO
RGD
PMID:22465320
RGD:6482178
NCBI chr 9:84,081,713...84,191,112
Ensembl chr 9:84,083,396...84,190,876
G
ICAM1
intercellular adhesion molecule 1
ISO
protein:increased expression:brain:
RGD
PMID:16230799
RGD:11522716
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
G
IFNL3
interferon lambda 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 6:33,843,140...33,845,444
G
IGF1
insulin like growth factor 1
treatment
ISO
human protein in a rat model
RGD
PMID:9344566
RGD:12904928
NCBI chr11:97,624,498...97,708,730
Ensembl chr11:97,631,189...97,707,308
G
IGF2
insulin like growth factor 2
ISO
mRNA:decreased expression:brain
RGD
PMID:11123717
RGD:5509972
NCBI chr 1:1,937,414...1,951,238
Ensembl chr 1:1,936,830...1,945,388
G
IL10
interleukin 10
severity treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21549006 PMID:23075771 PMID:23971414
RGD:7364822 RGD:7364983
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
G
IL12RB2
interleukin 12 receptor subunit beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr20:65,711,298...65,805,963
Ensembl chr20:65,714,618...65,791,681
G
IL13RA2
interleukin 13 receptor subunit alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr X:102,589,947...102,628,853
Ensembl chr X:102,590,045...102,603,260
G
IL16
interleukin 16
ISO
RGD
PMID:17983426
RGD:5024939
NCBI chr26:2,080,985...2,208,764
Ensembl chr26:2,077,228...2,208,431
G
IL17RD
interleukin 17 receptor D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr22:18,416,143...18,489,855
Ensembl chr22:18,416,443...18,434,271
G
IL18
interleukin 18
severity
ISO
mRNA, protein:increased expression:brain
RGD
PMID:17188500
RGD:2315917
NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
G
IL18R1
interleukin 18 receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr14:6,026,683...6,067,808
Ensembl chr14:6,026,443...6,066,884
G
IL1A
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:cerebral cortex
CTD RGD
PMID:16024175 PMID:21549006
RGD:2311098
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
G
IL1B
interleukin 1 beta
ISO
mRNA, protein:increased expression:brain CTD Direct Evidence: marker/mechanism protein:increased expression:brain, cerebrospinal fluid mRNA, protein:increased expression:cerebral cortex
RGD CTD
PMID:16024175 PMID:17612572 PMID:19800810 PMID:21549006 PMID:22503903
RGD:1626652 RGD:2311098 RGD:6482651
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
IL1R1
interleukin 1 receptor type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr14:5,781,486...5,852,872
Ensembl chr14:5,781,479...5,855,942
G
IL1RN
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25665855
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
G
IL2
interleukin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 7:69,729,635...69,736,279
Ensembl chr 7:69,730,282...69,734,969
G
IL3
interleukin 3
disease_progression
ISO
protein: increased expression: brain: microdialysis perfusate
RGD
PMID:20717122 PMID:21515263
RGD:5686795 RGD:5686886
NCBI chr23:34,894,630...34,899,105
G
IL31RA
interleukin 31 receptor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 4:52,062,910...52,156,732
Ensembl chr 4:52,101,410...52,155,428
G
IL4
interleukin 4
ISO
protein:decreased expression:plasma
RGD
PMID:24519543
RGD:10402802
NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
G
IL5
interleukin 5
treatment
ISO
RGD
PMID:24530657 PMID:24602693
RGD:11522766 RGD:11522770
NCBI chr23:35,360,143...35,375,169
Ensembl chr23:35,360,506...35,362,178
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:cerebrospinal fluid (rat)
CTD RGD
PMID:10027774 PMID:19800810 PMID:21549006 PMID:23159883
RGD:11049549
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
G
IL7
interleukin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 8:74,230,493...74,292,985
Ensembl chr 8:74,231,809...74,292,384
G
IL9R
interleukin 9 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr X:130,006,399...130,019,191
Ensembl chr X:130,006,899...130,020,894
G
IRF1
interferon regulatory factor 1
ISO
mRNA:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12503083 PMID:21549006
RGD:2317873
NCBI chr23:35,309,058...35,317,765
Ensembl chr23:35,307,772...35,316,763
G
JAK2
Janus kinase 2
ISO
RGD
PMID:21596098
RGD:6483023
NCBI chr12:74,421,243...74,566,766
Ensembl chr12:74,421,016...74,566,710
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr20:74,204,481...74,207,835
Ensembl chr20:74,205,542...74,206,546
G
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
ISO
RGD
PMID:20861444
RGD:8662901
NCBI chr20:3,873,915...3,907,587
Ensembl chr20:3,902,513...3,903,652
G
KDR
kinase insert domain receptor
ISO
protein:increased expression:cerebral cortex
RGD
PMID:19733172 PMID:21307798
RGD:5684382 RGD:5684402
NCBI chr 7:13,435,059...13,482,236
Ensembl chr 7:13,435,096...13,482,771
G
LEP
leptin
ISO
RGD
PMID:21276361
RGD:5128517
NCBI chr21:97,056,913...97,071,161
Ensembl chr21:97,057,529...97,071,220
G
LOC103221745
heat shock 70 kDa protein 1A
ISO
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21549006
RGD:5147593
NCBI chr17:40,203,647...40,206,028
Ensembl chr17:40,203,936...40,205,858
G
LOC103221883
uncharacterized LOC103221883
ISO
mRNA, protein:alternative form, decreased phosphorylation:brain
RGD
PMID:23057870
RGD:7327147
NCBI chr 4:55,148,012...56,665,684
Ensembl chr 4:55,153,563...55,390,027
G
LOC103223491
peroxisome proliferator-activated receptor alpha
ISO
agonist more effective in combination with simvastatin
RGD
PMID:18562561
RGD:5508455
NCBI chr19:28,614,892...28,709,272
Ensembl chr19:28,615,413...28,708,763
G
LOC103231892
metalloproteinase inhibitor 1
ISO
mRNA:increased expression:brain, astrocytes
RGD
PMID:10719361
RGD:2290468
NCBI chr X:44,759,412...44,763,243
Ensembl chr X:44,760,531...44,765,571
G
LOC103231899
ETS transcription factor ELK1
ISO
RGD
PMID:15362724
RGD:7488910
NCBI chr X:44,812,681...44,827,657
G
LOC103233018
liver carboxylesterase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr 5:41,710,500...41,745,483
G
LOC103246095
creatine kinase U-type, mitochondrial
treatment
ISO
RGD
PMID:24252176
RGD:11565089
NCBI chr26:39,397,797...39,401,046
G
LSG1
large 60S subunit nuclear export GTPase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14499481
NCBI chr15:88,729,016...88,758,421
Ensembl chr15:88,729,031...88,759,102
G
LY86
lymphocyte antigen 86
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr17:65,544,971...65,610,775
Ensembl chr17:65,547,690...65,610,639
G
MAG
myelin associated glycoprotein
susceptibility
ISO
RGD
PMID:17156367
RGD:9685230
NCBI chr 6:30,224,873...30,246,277
Ensembl chr 6:30,227,442...30,246,481
G
MAP1B
microtubule associated protein 1B
ISO
protein:increased expression, increased phosphorylation:brain
RGD
PMID:10906717
RGD:2304029
NCBI chr 4:66,445,687...66,548,595
Ensembl chr 4:66,445,901...66,549,142
G
MAP1LC3A
microtubule associated protein 1 light chain 3 alpha
ISO
RGD
PMID:24221859
RGD:11558018
NCBI chr 2:38,857,235...38,858,955
Ensembl chr 2:38,857,299...38,858,505
G
MAP2
microtubule associated protein 2
ISO
protein:decreased expression:cerebral cortex, neuron
RGD
PMID:20568963 PMID:21401443
RGD:6483087 RGD:6483089
NCBI chr10:95,319,649...95,431,106
Ensembl chr10:95,349,157...95,431,320
G
MAP3K7
mitogen-activated protein kinase kinase kinase 7
treatment
ISO
associated with Subarachnoid Hemorrhage
RGD
PMID:26100626 PMID:27000704 PMID:33414375
RGD:155791672 RGD:155804286 RGD:155882440
NCBI chr13:15,284,927...15,360,539
Ensembl chr13:15,284,923...15,360,832
G
MBL2
mannose binding lectin 2
disease_progression
ISO
RGD
PMID:18183030
RGD:12910935
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
G
MBP
myelin basic protein
ISO
RGD
PMID:18583256
RGD:7349333
NCBI chr18:2,844,154...2,996,640
Ensembl chr18:2,868,795...2,997,046
G
MDM2
MDM2 proto-oncogene
ISO
protein:increased expression:brain cortex (rat)
RGD
PMID:15165363
RGD:2317397
NCBI chr11:64,434,203...64,465,490
Ensembl chr11:64,434,261...64,469,890
G
MIF
macrophage migration inhibitory factor
ISO
RGD
PMID:15922484
RGD:1641989
NCBI chr19:7,000,837...7,001,700
Ensembl chr19:7,000,793...7,001,757
G
MMP9
matrix metallopeptidase 9
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16671440 PMID:19631748 PMID:24661104
RGD:13207312 RGD:1582656
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
G
MPO
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr16:35,120,194...35,130,851
Ensembl chr16:35,120,581...35,130,671
G
MT3
metallothionein 3
treatment
ISO
RGD
PMID:10218634 PMID:10595827 PMID:16314047
RGD:6480628 RGD:9685803 RGD:9685805
NCBI chr 5:42,502,306...42,504,467
G
MYOC
myocilin
ISO
mRNA:increased expression:cerebral cortex (rat)
RGD
PMID:12799138
RGD:7401267
NCBI chr25:57,458,615...57,475,329
Ensembl chr25:57,459,374...57,475,322
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
protein:increased expression:lung:
RGD
PMID:18787991 PMID:25089700
RGD:11576302 RGD:5134971
NCBI chr10:62,789,647...62,825,651
Ensembl chr10:62,790,124...62,825,339
G
NGB
neuroglobin
severity
ISO
RGD
PMID:21915648
RGD:9743963
NCBI chr24:54,510,877...54,518,535
Ensembl chr24:54,511,924...54,516,210
G
NGFR
nerve growth factor receptor
treatment
ISO
RGD
PMID:23940017
RGD:10414074
NCBI chr16:69,894,000...69,914,209
Ensembl chr16:69,894,139...69,912,189
G
NOS2
nitric oxide synthase 2
ISO
RGD
PMID:11526986
RGD:10395358
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
G
NOX4
NADPH oxidase 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36762617
NCBI chr 1:80,470,418...80,642,513
Ensembl chr 1:80,470,826...80,642,722
G
NPPB
natriuretic peptide B
ISO
associated with lung diseases;protein:increased expression:serum: CTD Direct Evidence: therapeutic
RGD CTD
PMID:19803787 PMID:23837838
RGD:7247620
NCBI chr20:119,930,931...119,933,391
Ensembl chr20:119,932,021...119,933,197
G
NPY
neuropeptide Y
ISO
protein:increased expression:adrenal medulla
RGD
PMID:23570732
RGD:10448961
NCBI chr21:34,068,533...34,076,205
Ensembl chr21:34,068,530...34,075,127
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
associated with Subarachnoid Hemorrhage mRNA:increased expression:lung
RGD
PMID:18787991 PMID:20864352
RGD:11035222 RGD:5134971
NCBI chr 5:57,676,547...57,695,434
Ensembl chr 5:57,675,981...57,716,599
G
NT5E
5'-nucleotidase ecto
ISO
protein:altered expression:cerebral cortex (rat)
RGD
PMID:21337375
RGD:5134348
NCBI chr13:10,115,591...10,162,178
Ensembl chr13:10,116,161...10,160,414
G
P2RY1
purinergic receptor P2Y1
ISO
protein:increased expression:brain, astrocyte
RGD
PMID:19115395
RGD:2315811
NCBI chr15:37,822,474...37,827,245
G
PALLD
palladin, cytoskeletal associated protein
ISO
protein:increased expression:brain, astrocyte
RGD
PMID:12932445
RGD:2325786
NCBI chr 7:114,758,017...115,173,240
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17640816
NCBI chr25:3,350,798...3,405,040
G
PAWR
pro-apoptotic WT1 regulator
ISO
mRNA,protein:increased expression:brain:
RGD
PMID:11421591
RGD:9835358
NCBI chr11:75,132,547...75,219,633
Ensembl chr11:75,133,186...75,219,072
G
PDGFA
platelet derived growth factor subunit A
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr28:21,044,549...21,068,411
Ensembl chr28:21,047,219...21,069,827
G
PDGFB
platelet derived growth factor subunit B
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr19:21,865,792...21,888,068
Ensembl chr19:21,863,768...21,886,395
G
PDGFRA
platelet derived growth factor receptor alpha
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr 7:14,243,291...14,307,373
Ensembl chr 7:14,241,070...14,307,422
G
PDGFRB
platelet derived growth factor receptor beta
ISO
mRNA:increased expression:cerebral cortex, hippocampus
RGD
PMID:9645955
RGD:11084932
NCBI chr23:52,724,061...52,766,264
Ensembl chr23:52,724,005...52,766,234
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
RGD
PMID:22658532
RGD:6484732
NCBI chr16:56,863,763...56,947,479
Ensembl chr16:56,880,934...56,950,999
G
PGLYRP1
peptidoglycan recognition protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr 6:39,474,077...39,478,635
Ensembl chr 6:39,474,170...39,477,914
G
PGR
progesterone receptor
ISO
RGD
PMID:23211561
RGD:7248711
NCBI chr 1:92,420,970...92,519,128
Ensembl chr 1:92,430,453...92,517,296
G
PHB1
prohibitin 1
ISO
protein:increased oxidation:cerebral cortex
RGD
PMID:17518533
RGD:2292409
NCBI chr16:69,805,968...69,816,792
Ensembl chr16:69,806,923...69,816,754
G
PHB2
prohibitin 2
ISO
RGD
PMID:24566151
RGD:12903261
NCBI chr11:6,998,517...7,004,437
G
PIAS1
protein inhibitor of activated STAT 1
ISO
protein:decreased expression:brain, nucleus
RGD
PMID:21545521
RGD:8693413
NCBI chr26:15,294,296...15,432,731
Ensembl chr26:15,297,934...15,432,659
G
PPARGC1A
PPARG coactivator 1 alpha
treatment
ISO
protein:decreased expression:frontal cortex (rat)
RGD
PMID:22642418 PMID:24345766
RGD:10059630 RGD:6484257
NCBI chr27:25,882,385...26,563,530
Ensembl chr27:26,465,499...26,564,582
G
PPP3CA
protein phosphatase 3 catalytic subunit alpha
ISO
protein: :hippocampus CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:14499481 PMID:19751097
RGD:6483311
NCBI chr 7:49,149,044...49,478,796
Ensembl chr 7:49,148,933...49,321,013
G
PRF1
perforin 1
ISO
RGD
PMID:20537642
RGD:6482807
NCBI chr 9:60,692,544...60,698,000
Ensembl chr 9:60,692,600...60,698,465
G
PTGER3
prostaglandin E receptor 3
ISO
protein:increased expression:striatum, microglia (rat)
RGD
PMID:15234107
RGD:9850280
NCBI chr20:62,093,830...62,293,360
Ensembl chr20:62,095,458...62,174,959
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:microglia, macrophage protein:increased expression:microglial cells, macrophage, endothelial cell
RGD
PMID:11565600 PMID:12005397 PMID:19719848
RGD:5688162 RGD:5688239 RGD:5688242
NCBI chr12:17,195,403...17,218,450
Ensembl chr12:17,192,628...17,218,315
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12410334 PMID:19719848 PMID:20810888 PMID:21549006 PMID:21866634
RGD:5508191 RGD:5688162
NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
G
PTPRZ1
protein tyrosine phosphatase receptor type Z1
ISO
RGD
PMID:12088737
RGD:727637
NCBI chr21:90,686,091...90,877,538
Ensembl chr21:90,686,167...90,877,649
G
RCHY1
ring finger and CHY zinc finger domain containing 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:21728064
RGD:10045359
NCBI chr 7:23,989,028...24,025,151
Ensembl chr 7:23,989,745...24,025,437
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
protein:increased expression:ileum
RGD
PMID:18288455
RGD:2298787
NCBI chr 1:8,576,059...8,585,561
Ensembl chr 1:8,576,542...8,586,516
G
RET
ret proto-oncogene
ISO
mRNA:increased expression:brain
RGD
PMID:18501516
RGD:2324932
NCBI chr 9:38,746,088...38,798,773
Ensembl chr 9:38,769,170...38,796,712
G
RHOA
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17929039
RGD:2298888
NCBI chr22:10,757,381...10,809,257
Ensembl chr22:10,757,337...10,772,704
G
ROBO1
roundabout guidance receptor 1
ISO
mRNA:increased expression:brain protein:increased expression:brain, immune cell
RGD
PMID:16262652 PMID:26550694
RGD:2316136 RGD:243048437
NCBI chr22:97,178,093...98,363,647
Ensembl chr22:98,222,891...98,363,219
G
ROBO2
roundabout guidance receptor 2
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr22:99,334,033...101,101,924
G
ROBO3
roundabout guidance receptor 3
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr 1:116,004,129...116,024,691
Ensembl chr 1:116,008,742...116,024,474
G
RPS27A
ribosomal protein S27a
ISO
mRNA:decreased expression:cerebral cortex, hippocampus
RGD
PMID:17936732
RGD:11041870
NCBI chr14:51,664,098...51,667,138
Ensembl chr14:51,664,101...51,667,011
G
S100B
S100 calcium binding protein B
severity
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:11520488 PMID:21783483 PMID:21976236
RGD:5508761
NCBI chr 2:90,188,820...90,194,986
Ensembl chr 2:90,188,639...90,195,023
G
SELE
selectin E
ISO
protein:increased expression:brain
RGD
PMID:19107536
RGD:2313599
NCBI chr25:59,305,610...59,333,789
Ensembl chr25:59,322,913...59,330,668
G
SERPINC1
serpin family C member 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21534203
NCBI chr25:55,271,823...55,289,855
G
SERPINF1
serpin family F member 1
treatment
ISO
human gene in a rat model protein:altered expression:cerebellum (rat)
RGD
PMID:17709187 PMID:20142768
RGD:8612994 RGD:8622925
NCBI chr16:1,408,453...1,424,197
G
SIRT1
sirtuin 1
treatment
ISO
RGD
PMID:17970622
RGD:9497541
NCBI chr 9:63,463,059...63,497,893
Ensembl chr 9:63,462,389...63,497,867
G
SKP2
S-phase kinase associated protein 2
ISO
protein:increased expression:brain
RGD
PMID:19852587
RGD:2315049
NCBI chr 4:35,009,114...35,040,518
Ensembl chr 4:35,009,076...35,042,632
G
SLC18A3
solute carrier family 18 member A3
ISO
protein:decreased expression:brain
RGD
PMID:18848922
RGD:5686682
NCBI chr 9:42,216,187...42,219,665
Ensembl chr 9:42,216,568...42,218,166
G
SLIT1
slit guidance ligand 1
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr 9:90,166,710...90,357,983
Ensembl chr 9:90,172,578...90,237,256
G
SLIT2
slit guidance ligand 2
exacerbates
ISO
RGD
PMID:26550694
RGD:243048437
NCBI chr27:29,650,589...30,020,105
Ensembl chr27:29,650,337...29,803,612
G
SLIT3
slit guidance ligand 3
ISO
mRNA:increased expression:brain
RGD
PMID:16262652
RGD:2316136
NCBI chr23:70,890,096...71,524,002
Ensembl chr23:70,885,737...71,106,703
G
SNCA
synuclein alpha
ISO
RGD
PMID:14637093 PMID:25089700
RGD:11576302 RGD:6480195
NCBI chr 7:38,083,154...38,194,068
Ensembl chr 7:38,081,509...38,191,479
G
SNCB
synuclein beta
ISO
RGD
PMID:14637093
RGD:6480195
NCBI chr23:78,626,876...78,637,337
Ensembl chr23:78,627,479...78,636,287
G
SNCG
synuclein gamma
ISO
RGD
PMID:14637093
RGD:6480195
NCBI chr 9:44,907,840...44,914,750
Ensembl chr 9:44,907,728...44,912,510
G
SNW1
SNW domain containing 1
ISO
mRNA, protein:increased expression:cerebral cortex (rat)
RGD
PMID:22965216
RGD:11035237
NCBI chr24:54,976,597...55,020,051
Ensembl chr24:54,977,083...55,019,988
G
SOD1
superoxide dismutase 1
ISO
RGD
PMID:16248885
RGD:1581214
NCBI chr 2:60,461,219...60,472,999
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:16248885 PMID:24462953
RGD:1581214
NCBI chr13:87,284,537...87,297,998
Ensembl chr13:87,280,686...87,297,974
G
SPARC
secreted protein acidic and cysteine rich
ISO
mRNA:increased expression:brain, blood vessel
RGD
PMID:9704602
RGD:2300066
NCBI chr23:54,224,003...54,248,869
Ensembl chr23:54,222,838...54,238,006
G
SSTR2
somatostatin receptor 2
ISO
RGD
PMID:11879809
RGD:2325002
NCBI chr16:48,462,472...48,470,586
Ensembl chr16:48,464,342...48,465,451
G
SSTR3
somatostatin receptor 3
ISO
RGD
PMID:11879809
RGD:2325002
NCBI chr19:19,908,562...19,916,787
Ensembl chr19:19,910,898...19,912,154
G
SSTR4
somatostatin receptor 4
ISO
RGD
PMID:11879809
RGD:2325002
NCBI chr 2:52,027,241...52,034,777
Ensembl chr 2:52,031,021...52,032,187
G
STAT1
signal transducer and activator of transcription 1
ISO
RGD
PMID:21596098
RGD:6483023
NCBI chr10:76,492,859...76,537,689
Ensembl chr10:76,492,533...76,533,393
G
STAT3
signal transducer and activator of transcription 3
ISO
protein:increased phosphorylation:brain
RGD
PMID:21596098 PMID:22145815 PMID:22827467
RGD:6483023 RGD:6892706 RGD:8694312
NCBI chr16:63,877,884...63,957,894
Ensembl chr16:63,922,862...63,957,984
G
STRN
striatin
ISO
RGD
PMID:16351572
RGD:2311293
NCBI chr14:70,437,593...70,563,631
Ensembl chr14:70,437,570...70,558,013
G
TARDBP
TAR DNA binding protein
ISO
RGD
PMID:22101322
RGD:5687195
NCBI chr20:120,753,764...120,765,259
G
TF
transferrin
ISO
RGD
PMID:22538758
RGD:7244386
NCBI chr15:56,586,311...56,618,304
Ensembl chr15:56,586,104...56,618,149
G
TH
tyrosine hydroxylase
ISO
protein:decreased activity:striatum (rat)
RGD
PMID:21047500
RGD:5128822
NCBI chr 1:1,969,194...1,977,263
Ensembl chr 1:1,966,460...1,977,218
G
THBD
thrombomodulin
onset
ISO
RGD
PMID:17895610
RGD:5685007
NCBI chr 2:52,041,950...52,045,946
Ensembl chr 2:52,043,746...52,045,626
G
TICAM2
toll like receptor adaptor molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr23:18,831,361...18,855,476
Ensembl chr23:18,833,262...18,833,969
G
TIMP2
TIMP metallopeptidase inhibitor 2
ISO
mRNA:increased expression:brain, neuron, microglial cell
RGD
PMID:10719361
RGD:2290468
NCBI chr16:70,819,591...70,850,471
Ensembl chr16:70,819,139...70,850,471
G
TJP1
tight junction protein 1
ISO
RGD
PMID:19889224
RGD:2325128
NCBI chr26:52,623,751...52,750,037
Ensembl chr26:52,622,743...52,749,950
G
TLR1
toll like receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549006
NCBI chr27:11,482,307...11,490,847
Ensembl chr27:11,488,294...11,490,654
G
TLR2
toll like receptor 2
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:brain
CTD RGD
PMID:18316784 PMID:21549006
RGD:2312713
NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
G
TLR4
toll like receptor 4
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:brain
CTD RGD
PMID:18316784 PMID:21549006
RGD:2312713
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10674461 PMID:19800810 PMID:21549006
RGD:13825262
G
TNFRSF13B
TNF receptor superfamily member 13B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr16:15,980,927...16,012,572
Ensembl chr16:15,981,392...15,993,593
G
TNFRSF13C
TNF receptor superfamily member 13C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr19:24,457,381...24,459,438
G
TNFRSF14
TNF receptor superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr20:128,992,572...128,999,829
Ensembl chr20:128,992,489...129,000,338
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:brain
CTD RGD
PMID:17074049 PMID:21549006
RGD:1624183
NCBI chr11:6,364,544...6,378,880
Ensembl chr11:6,364,330...6,378,902
G
TNFSF10
TNF superfamily member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr15:16,934,982...16,953,155
Ensembl chr15:16,934,962...16,954,860
G
TNFSF12
TNF superfamily member 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr16:6,926,302...6,935,070
G
TRAF4
TNF receptor associated factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23159883
NCBI chr16:22,507,915...22,513,956
Ensembl chr16:22,507,835...22,515,335
G
TRPM2
transient receptor potential cation channel subfamily M member 2
ISO
mRNA, protein:increased expression:cerebral cortex, hippocampus
RGD
PMID:20309649
RGD:9999437
NCBI chr 2:88,082,391...88,170,340
Ensembl chr 2:88,087,448...88,170,344
G
UBA52
ubiquitin A-52 residue ribosomal protein fusion product 1
ISO
mRNA:decreased expression:cerebral cortex, hippocampus (rat)
RGD
PMID:17936732
RGD:11041870
NCBI chr 6:17,040,127...17,043,569
Ensembl chr 6:17,040,064...17,045,737
G
UCP2
uncoupling protein 2
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12858170
RGD:7204436
NCBI chr 1:65,238,311...65,246,841
Ensembl chr 1:65,235,775...65,246,450
G
VEGFA
vascular endothelial growth factor A
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:12230324 PMID:18065154
RGD:1580574
NCBI chr17:28,377,959...28,394,508
G
VEGFB
vascular endothelial growth factor B
ISO
mRNA, protein:increased expression:brain
RGD
PMID:12230324
RGD:1580574
NCBI chr 1:9,997,820...10,001,518
Ensembl chr 1:9,997,665...10,001,429
G
VIM
vimentin
ISO
protein:increased expression:brain
RGD
PMID:15527750 PMID:19728994
RGD:6480519 RGD:6480527
NCBI chr 9:17,183,466...17,191,771
Ensembl chr 9:17,183,388...17,191,829
G
XDH
xanthine dehydrogenase
treatment
ISO
RGD
PMID:26528358
RGD:13208950
NCBI chr14:76,084,693...76,162,840
Ensembl chr14:76,085,368...76,163,936
G
APOE
apolipoprotein E
susceptibility
ISO
DNA:polymorphism:exon:
RGD
PMID:9214529
RGD:7495763
NCBI chr 6:38,377,154...38,381,219
Ensembl chr 6:38,376,887...38,381,438
G
TARDBP
TAR DNA binding protein
ISO
protein:increased expression:brain
RGD
PMID:20720505
RGD:5687179
NCBI chr20:120,753,764...120,765,259
G
BECN1
beclin 1
ISO
protein:increased expression:neuron
RGD
PMID:16004578
RGD:6483315
NCBI chr16:63,469,187...63,482,627
Ensembl chr16:63,469,192...63,485,322
G
GFAP
glial fibrillary acidic protein
ISO
RGD
PMID:8833197
RGD:6480531
NCBI chr16:61,489,090...61,499,672
Ensembl chr16:61,489,421...61,500,646
G
GOT1
glutamic-oxaloacetic transaminase 1
ISO
human protein in a rat model
RGD
PMID:17014847
RGD:13504858
NCBI chr 9:92,463,017...92,489,227
Ensembl chr 9:92,462,782...92,488,310
G
IGF1
insulin like growth factor 1
ISO
protein:decreased expression:serum:
RGD
PMID:12002507
RGD:8548865
NCBI chr11:97,624,498...97,708,730
Ensembl chr11:97,631,189...97,707,308
G
IGFBP3
insulin like growth factor binding protein 3
ISO
protein:decreased expression:serum:
RGD
PMID:12002507
RGD:8548865
NCBI chr21:12,905,309...12,914,199
Ensembl chr21:12,905,280...12,914,205
G
VIM
vimentin
ISO
RGD
PMID:8833197
RGD:6480531
NCBI chr 9:17,183,466...17,191,771
Ensembl chr 9:17,183,388...17,191,829
G
ALDH3A1
aldehyde dehydrogenase 3 family member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28038895
NCBI chr16:18,302,145...18,312,768
Ensembl chr16:18,302,142...18,312,756
G
TP63
tumor protein p63
ISO
RGD
PMID:12167247
RGD:11568649
NCBI chr15:83,861,489...84,126,675
G
IFNG
interferon gamma
ISO
mRNA,protein:increased expression:corneal
RGD
PMID:15832292
RGD:8157597
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
G
BMP4
bone morphogenetic protein 4
ISO
mRNA:increased expression:superior cervical ganglion
RGD
PMID:16420416
RGD:2289006
NCBI chr24:31,097,673...31,104,774
Ensembl chr24:31,097,538...31,101,225
G
LOC103233058
fractalkine
ISO
RGD
PMID:15153618
RGD:4891994
NCBI chr 5:43,310,711...43,323,533
Ensembl chr 5:43,310,753...43,323,529
G
S100B
S100 calcium binding protein B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30076900
NCBI chr 2:90,188,820...90,194,986
Ensembl chr 2:90,188,639...90,195,023
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:22553604
RGD:7364851
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
G
IL1B
interleukin 1 beta
ISO
protein:increased expression:retina
RGD
PMID:9618720
RGD:7794723
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:cornea, neutrophil, macrophage (rat)
RGD
PMID:24194635
RGD:8552904
NCBI chr22:48,262,743...48,407,415
Ensembl chr22:48,275,600...48,407,418
G
FGF2
fibroblast growth factor 2
ISO
protein:increased expression:lens
RGD
PMID:15273655
RGD:8655664
NCBI chr 7:70,089,394...70,157,423
G
PPARG
peroxisome proliferator activated receptor gamma
treatment
ISO
RGD
PMID:18658087
RGD:8552893
NCBI chr22:48,262,743...48,407,415
Ensembl chr22:48,275,600...48,407,418
G
ADCYAP1
adenylate cyclase activating polypeptide 1
ISO
mRNA:increased expression:facial VII nucleus
RGD
PMID:19427307
RGD:2325258
NCBI chr18:60,259,479...60,267,302
G
ATF2
activating transcription factor 2
ISO
RGD
PMID:9813301
RGD:10047413
NCBI chr10:60,644,623...60,734,465
Ensembl chr10:60,644,635...60,734,475
G
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:19922414
RGD:6892922
NCBI chr22:7,648,410...7,698,523
Ensembl chr22:7,697,068...7,698,135
G
CD59
CD59 molecule (CD59 blood group)
ISO
mRNA, protein:increased expression:facial VII nucleus
RGD
PMID:9846834
RGD:1600495
NCBI chr 1:31,547,876...31,571,720
Ensembl chr 1:31,547,937...31,570,835
G
CLU
clusterin
ISO
protein:increased expression:neuron,astrocyte
RGD
PMID:10800205
RGD:408418725
NCBI chr 8:25,704,441...25,721,789
Ensembl chr 8:25,703,257...25,721,789
G
CSF1
colony stimulating factor 1
ISO
protein:increased expression:facial VII nerve, microglial cell
RGD
PMID:20831658
RGD:5131509
NCBI chr20:23,615,107...23,635,399
G
CTSS
cathepsin S
ISO
RGD
PMID:17539023
RGD:5686912
G
GFRA1
GDNF family receptor alpha 1
ISO
mRNA:increased expression:facial VII nucleus
RGD
PMID:9582449
RGD:6218984
NCBI chr 9:108,869,444...109,088,803
Ensembl chr 9:108,876,855...109,087,488
G
HGF
hepatocyte growth factor
treatment
ISO
RGD
PMID:21562589
RGD:8548634
NCBI chr21:67,118,785...67,193,506
Ensembl chr21:67,120,722...67,193,504
G
MT3
metallothionein 3
treatment
ISO
RGD
PMID:14625437
RGD:9685806
NCBI chr 5:42,502,306...42,504,467
G
NDUFA5
NADH:ubiquinone oxidoreductase subunit A5
ISO
mRNA:increased expression:skeletal muscle
RGD
PMID:8875451
RGD:2302319
NCBI chr21:92,330,693...92,348,567
Ensembl chr21:92,327,822...92,348,591
G
RET
ret proto-oncogene
ISO
mRNA:increased expression:facial VII nucleus
RGD
PMID:9582449
RGD:6218984
NCBI chr 9:38,746,088...38,798,773
Ensembl chr 9:38,769,170...38,796,712
G
ACVR1B
activin A receptor type 1B
ISO
RGD
PMID:9013782
RGD:151665480
NCBI chr11:48,120,765...48,166,520
Ensembl chr11:48,145,003...48,166,813
G
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
mRNA:increased expression:hypoglossal nerve
RGD
PMID:11311987
RGD:5037239
NCBI chr 2:65,376,288...65,385,398
Ensembl chr 2:65,376,310...65,385,918
G
AIF1
allograft inflammatory factor 1
ISO
RGD
PMID:9698327
RGD:704401
G
CSNK2B
casein kinase 2 beta
ISO
RGD
PMID:11068334
RGD:11565824
NCBI chr17:40,354,520...40,359,136
Ensembl chr17:40,352,367...40,358,401
G
FGF2
fibroblast growth factor 2
ISO
RGD
PMID:9183688
RGD:8655640
NCBI chr 7:70,089,394...70,157,423
G
FGFR1
fibroblast growth factor receptor 1
ISO
RGD
PMID:9183688
RGD:8655640
NCBI chr 8:36,426,116...36,485,683
Ensembl chr 8:36,427,110...36,485,508
G
GFRA1
GDNF family receptor alpha 1
ISO
mRNA:increased expression:hypoglossal XII nerve
RGD
PMID:10407179
RGD:6218979
NCBI chr 9:108,869,444...109,088,803
Ensembl chr 9:108,876,855...109,087,488
G
IL1R1
interleukin 1 receptor type 1
ISO
mRNA:increased expression:hypoglossal nerve
RGD
PMID:11311987
RGD:5037239
NCBI chr14:5,781,486...5,852,872
Ensembl chr14:5,781,479...5,855,942
G
MCAM
melanoma cell adhesion molecule
ISO
RGD
PMID:10076889
RGD:7364787
NCBI chr 1:110,682,631...110,691,717
Ensembl chr 1:110,684,458...110,691,707
G
MME
membrane metalloendopeptidase
ISO
RGD
PMID:8201016
RGD:13801045
NCBI chr15:35,577,460...35,681,730
Ensembl chr15:35,580,714...35,633,914
G
PRKACA
protein kinase cAMP-activated catalytic subunit alpha
ISO
RGD
PMID:7769990
RGD:7327191
NCBI chr 6:12,743,752...12,759,155
G
PRKACB
protein kinase cAMP-activated catalytic subunit beta
ISO
RGD
PMID:7769990
RGD:7327191
NCBI chr20:49,109,774...49,273,200
Ensembl chr20:49,108,425...49,178,806
G
RET
ret proto-oncogene
ISO
mRNA:increased expression:hypoglossal XII nerve
RGD
PMID:10407179
RGD:6218979
NCBI chr 9:38,746,088...38,798,773
Ensembl chr 9:38,769,170...38,796,712
G
SMAD1
SMAD family member 1
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr 7:92,047,273...92,123,451
Ensembl chr 7:92,079,914...92,123,429
G
SMAD2
SMAD family member 2
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr18:33,017,138...33,105,320
Ensembl chr18:33,017,492...33,104,606
G
SMAD3
SMAD family member 3
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr26:16,319,959...16,446,472
Ensembl chr26:16,320,933...16,446,527
G
SMAD4
SMAD family member 4
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr18:29,894,157...29,951,445
Ensembl chr18:29,897,621...29,934,478
G
SMAD7
SMAD family member 7
ISO
mRNA:increased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr18:31,993,543...32,024,088
Ensembl chr18:31,993,681...32,024,850
G
SMAD9
SMAD family member 9
ISO
mRNA:decreased expression:hypoglossal nucleus
RGD
PMID:17166487
RGD:1643227
NCBI chr 3:15,369,119...15,444,599
Ensembl chr 3:15,372,933...15,405,836
G
TXNRD1
thioredoxin reductase 1
ISO
mRNA, protein:increased expression:neuron
RGD
PMID:19833109
RGD:5133729
NCBI chr11:99,375,740...99,559,929
Ensembl chr11:99,490,597...99,560,267
G
GP6
glycoprotein VI platelet
exacerbates
ISO
RGD
PMID:21258336
RGD:401824683
NCBI chr 6:47,614,221...47,630,020
Ensembl chr 6:47,614,384...47,624,160
G
MDM2
MDM2 proto-oncogene
treatment
ISO
RGD
PMID:34334113
RGD:155882538
NCBI chr11:64,434,203...64,465,490
Ensembl chr11:64,434,261...64,469,890
G
ZEB2
zinc finger E-box binding homeobox 2
treatment
ISO
protein:increased expression:brain (rat)
RGD
PMID:34334113
RGD:155882538
NCBI chr10:29,732,934...29,864,157
Ensembl chr10:29,729,305...29,864,205
G
CITED2
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2
ISO
mRNA:decreased expression:bone
RGD
PMID:19607804
RGD:5147852
NCBI chr13:34,009,527...34,011,924
Ensembl chr13:34,010,228...34,011,046
G
IHH
Indian hedgehog signaling molecule
ISO
RGD
PMID:23992905
RGD:12911207
NCBI chr10:104,960,296...104,966,596
Ensembl chr10:104,960,120...104,966,585
G
NTRK2
neurotrophic receptor tyrosine kinase 2
ISO
mRNA:increased expression:motor neuron
RGD
PMID:21456016
RGD:5684341
NCBI chr12:95,477,612...95,836,734
Ensembl chr12:95,479,447...95,620,364
G
ADCY10
adenylate cyclase 10
ISO
protein:decreased expression:retina
RGD
PMID:22649251
RGD:329347828
NCBI chr25:61,129,837...61,228,180
Ensembl chr25:61,140,293...61,230,117
G
ADNP
activity dependent neuroprotector homeobox
ISO
RGD
PMID:18414890
RGD:2312783
NCBI chr 2:13,037,446...13,080,287
Ensembl chr 2:13,039,866...13,081,161
G
AMIGO3
adhesion molecule with Ig like domain 3
treatment
ISO
RGD
PMID:23613963
RGD:14390159
NCBI chr22:11,111,871...11,115,104
Ensembl chr22:11,112,953...11,114,467
G
AQP4
aquaporin 4
ISO
RGD
PMID:20216911
RGD:2326035
NCBI chr18:53,729,143...53,742,916
Ensembl chr18:53,729,186...53,743,156
G
AQP9
aquaporin 9
ISO
RGD
PMID:20216911
RGD:2326035
NCBI chr26:25,326,108...25,374,743
Ensembl chr26:25,326,087...25,373,336
G
ARG2
arginase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30618589
NCBI chr24:44,851,139...44,884,118
Ensembl chr24:44,851,175...44,883,853
G
ATF2
activating transcription factor 2
ISO
RGD
PMID:10366744
RGD:10047417
NCBI chr10:60,644,623...60,734,465
Ensembl chr10:60,644,635...60,734,475
G
BAX
BCL2 associated X, apoptosis regulator
ISO
mRNA:increased expression:optic nerve, retina
RGD
PMID:24357921
RGD:10054098
NCBI chr 6:42,186,028...42,193,105
G
BCL2
BCL2 apoptosis regulator
ISO
mRNA:decreased expression:optic nerve, retina
RGD
PMID:24357921
RGD:10054098
NCBI chr18:16,440,560...16,643,187
Ensembl chr18:16,441,733...16,637,895
G
BDNF
brain derived neurotrophic factor
treatment
ISO
RGD
PMID:9520478 PMID:11050383 PMID:15140649
RGD:8655584 RGD:8655586 RGD:8655637
NCBI chr 1:37,386,825...37,451,380
Ensembl chr 1:37,449,593...37,450,336
G
C3
complement C3
ISO
mRNA:increased expression:optic nerve
RGD
PMID:14577867
RGD:5129542
NCBI chr 6:6,250,422...6,289,264
G
CDK2
cyclin dependent kinase 2
ISO
mRNA:increased expression:retina
RGD
PMID:16723461
RGD:2293567
NCBI chr11:51,905,085...51,910,209
Ensembl chr11:51,905,115...51,909,907
G
CFL1
cofilin 1
treatment
ISO
RGD
PMID:27443501
RGD:11568693
NCBI chr 1:8,408,560...8,410,564
G
CLU
clusterin
ISO
RGD
PMID:14577867
RGD:5129542
NCBI chr 8:25,704,441...25,721,789
Ensembl chr 8:25,703,257...25,721,789
G
CSF1R
colony stimulating factor 1 receptor
ISO
mRNA:increased expression:retina (rat)
RGD
PMID:20187850
RGD:151665810
NCBI chr23:52,663,290...52,723,652
Ensembl chr23:52,664,076...52,697,304
G
CSF3
colony stimulating factor 3
treatment
ISO
RGD
PMID:20144610
RGD:11039471
NCBI chr16:66,162,814...66,166,192
Ensembl chr16:66,163,681...66,165,172
G
CTSB
cathepsin B
ISO
protein:increased expression:retina (rat)
RGD
PMID:18775855
RGD:2315508
NCBI chr 8:7,246,076...7,269,655
Ensembl chr 8:7,246,013...7,268,854
G
EDN1
endothelin 1
ISO
protein:increased expression:retina
RGD
PMID:18600494
RGD:4892579
NCBI chr17:59,854,186...59,861,319
Ensembl chr17:59,853,699...59,861,198
G
EDNRA
endothelin receptor type A
ISO
mRNA:increased expression:retina
RGD
PMID:18600494
RGD:4892579
NCBI chr 7:93,980,983...94,043,863
Ensembl chr 7:93,985,797...94,042,296
G
EDNRB
endothelin receptor type B
ISO
mRNA:increased expression:retina
RGD
PMID:18600494
RGD:4892579
NCBI chr 3:56,969,493...56,993,719
Ensembl chr 3:56,969,101...56,992,731
G
EP300
E1A binding protein p300
ISO
human gene in rat model protein:decreased expression:retinal ganglion cell layer (rat)
RGD
PMID:21705428
RGD:7349392
NCBI chr19:23,634,132...23,726,095
Ensembl chr19:23,634,571...23,724,979
G
FGF2
fibroblast growth factor 2
treatment
ISO
RGD
PMID:14664816
RGD:8554854
NCBI chr 7:70,089,394...70,157,423
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
mRNA:increased expression:retina
RGD
PMID:33664770
RGD:329951020
NCBI chr 5:39,487,304...39,900,238
Ensembl chr 5:39,487,418...39,725,747
G
GDNF
glial cell derived neurotrophic factor
ISO
RGD
PMID:15144875
RGD:6218970
NCBI chr 4:36,662,033...36,691,761
Ensembl chr 4:36,665,009...36,684,257
G
GFRA1
GDNF family receptor alpha 1
ISO
RGD
PMID:15144875
RGD:6218970
NCBI chr 9:108,869,444...109,088,803
Ensembl chr 9:108,876,855...109,087,488
G
GFRA2
GDNF family receptor alpha 2
ISO
RGD
PMID:15144875
RGD:6218970
NCBI chr 8:19,767,027...19,866,955
Ensembl chr 8:19,766,917...19,866,965
G
HGF
hepatocyte growth factor
treatment
ISO
RGD
PMID:21443522
RGD:8548549
NCBI chr21:67,118,785...67,193,506
Ensembl chr21:67,120,722...67,193,504
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein: altered activity: eye protein:increased expression:retina:
RGD
PMID:19484445 PMID:23648097
RGD:10046025 RGD:5686431
NCBI chr29:17,212,206...17,534,036
Ensembl chr29:17,459,404...17,526,930
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
RGD
PMID:10366744
RGD:10047417
NCBI chr20:74,204,481...74,207,835
Ensembl chr20:74,205,542...74,206,546
G
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
ISO
RGD
PMID:20216911
RGD:2326035
NCBI chr20:3,873,915...3,907,587
Ensembl chr20:3,902,513...3,903,652
G
MYRF
myelin regulatory factor
ISO
mRNA:decreased expression: oligodendrocyte
RGD
PMID:29915135
RGD:213230153
NCBI chr 1:12,066,277...12,103,091
G
NAMPT
nicotinamide phosphoribosyltransferase
treatment
ISO
RGD
PMID:28032230
RGD:13781885
NCBI chr21:75,160,748...75,195,781
Ensembl chr21:75,158,596...75,196,025
G
NCAM1
neural cell adhesion molecule 1
ISO
RGD
PMID:18757519
RGD:2326023
NCBI chr 1:104,332,622...104,647,258
G
NEFM
neurofilament medium chain
ISO
RGD
PMID:8501527
RGD:9743936
NCBI chr 8:23,039,187...23,044,668
Ensembl chr 8:23,039,282...23,044,667
G
NEO1
neogenin 1
ISO
protein:increased expression:retina
RGD
PMID:21887516
RGD:9850142
NCBI chr26:10,173,707...10,427,732
Ensembl chr26:10,176,215...10,427,675
G
NGF
nerve growth factor
ISO
protein:increased expression:retina
RGD
PMID:28067793
RGD:402463954
NCBI chr20:18,361,795...18,413,987
Ensembl chr20:18,413,108...18,413,833
G
NGFR
nerve growth factor receptor
ISO
RGD
PMID:20943663
RGD:5508695
NCBI chr16:69,894,000...69,914,209
Ensembl chr16:69,894,139...69,912,189
G
NTRK1
neurotrophic receptor tyrosine kinase 1
ISO
RGD
PMID:20943663
RGD:5508695
NCBI chr20:6,987,903...7,027,381
Ensembl chr20:6,987,905...7,008,670
G
NTRK2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:20357199 PMID:34245756
RGD:5684908 RGD:597015764
NCBI chr12:95,477,612...95,836,734
Ensembl chr12:95,479,447...95,620,364
G
PAWR
pro-apoptotic WT1 regulator
ISO
mRNA:increased expression:retina:
RGD
PMID:12836167
RGD:1299297
NCBI chr11:75,132,547...75,219,633
Ensembl chr11:75,133,186...75,219,072
G
PAX6
paired box 6
ISO
protein:increased expression:retina (rat)
RGD
PMID:23297010
RGD:8552379
NCBI chr 1:33,386,165...33,414,605
Ensembl chr 1:33,392,970...33,414,587
G
PDGFB
platelet derived growth factor subunit B
ISO
protein:decreased expression:nerve fiber:
RGD
PMID:9893812
RGD:10449496
NCBI chr19:21,865,792...21,888,068
Ensembl chr19:21,863,768...21,886,395
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
protein:increased expression:optic nerve (rat)
RGD
PMID:22336118
RGD:6767293
NCBI chr16:56,863,763...56,947,479
Ensembl chr16:56,880,934...56,950,999
G
PLAU
plasminogen activator, urokinase
ISO
mRNA:increased expression:optic nerve (rat)
RGD
PMID:20798533
RGD:6483802
NCBI chr 9:57,452,904...57,459,345
Ensembl chr 9:57,452,761...57,459,286
G
PTPN5
protein tyrosine phosphatase non-receptor type 5
ISO
protein:increased expression:retina (rat)
RGD
PMID:15555919
RGD:9835027
NCBI chr 1:46,134,109...46,197,246
Ensembl chr 1:46,153,340...46,199,002
G
RHOA
ras homolog family member A
ISO
protein:increased expression, altered localization:retina
RGD
PMID:17534117
RGD:1642826
NCBI chr22:10,757,381...10,809,257
Ensembl chr22:10,757,337...10,772,704
G
SNW1
SNW domain containing 1
ISO
protein:increased expression:retina (rat)
RGD
PMID:25074585
RGD:11035254
NCBI chr24:54,976,597...55,020,051
Ensembl chr24:54,977,083...55,019,988
G
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:19661221
RGD:597538516
NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
G
TLR4
toll like receptor 4
ISO
protein:increased expression:optic nerve
RGD
PMID:23103505
RGD:7794777
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
RGD
PMID:14697498 PMID:18552980
RGD:7794683 RGD:8661743
NCBI chr11:6,364,544...6,378,880
Ensembl chr11:6,364,330...6,378,902
G
TRADD
TNFRSF1A associated via death domain
ISO
protein:increased expression: retina
RGD
PMID:18552980
RGD:7794683
NCBI chr 5:60,296,777...60,303,076
Ensembl chr 5:60,297,375...60,303,579
G
YBX3
Y-box binding protein 3
ISO
mRNA:increased expression:retinal ganglion cell
RGD
PMID:11750989
RGD:2311250
NCBI chr11:10,498,162...10,522,432
Ensembl chr11:10,500,361...10,522,226
G
FGF2
fibroblast growth factor 2
ISO
mRNA:increased expression:retina
RGD
PMID:9268592
RGD:8655567
NCBI chr 7:70,089,394...70,157,423
G
NEO1
neogenin 1
ISO
protein:increased expression:retina
RGD
PMID:21887516
RGD:9850142
NCBI chr26:10,173,707...10,427,732
Ensembl chr26:10,176,215...10,427,675
G
RGMA
repulsive guidance molecule BMP co-receptor a
ISO
protein:increased expression:retina
RGD
PMID:21887516
RGD:9850142
NCBI chr29:11,592,929...11,638,955
Ensembl chr29:11,592,604...11,638,860
G
ENTPD1
ectonucleoside triphosphate diphosphohydrolase 1
ISO
protein:increased expression,increased activity:cerebral cortex:
RGD
PMID:16672190
RGD:9685448
NCBI chr 9:88,921,826...89,034,418
Ensembl chr 9:88,922,007...89,032,880
G
FGFR1
fibroblast growth factor receptor 1
ISO
mRNA,protein:increased expression:astrocyte,macrophage,neutrophil:
RGD
PMID:11168551
RGD:10402049
NCBI chr 8:36,426,116...36,485,683
Ensembl chr 8:36,427,110...36,485,508
G
GFAP
glial fibrillary acidic protein
ISO
RGD
PMID:10225952
RGD:6480471
NCBI chr16:61,489,090...61,499,672
Ensembl chr16:61,489,421...61,500,646
G
PDGFB
platelet derived growth factor subunit B
ISO
protein:increased expression:neuron:
RGD
PMID:7526956
RGD:10449485
NCBI chr19:21,865,792...21,888,068
Ensembl chr19:21,863,768...21,886,395
G
VIM
vimentin
ISO
RGD
PMID:10225952
RGD:6480471
NCBI chr 9:17,183,466...17,191,771
Ensembl chr 9:17,183,388...17,191,829
G
TRH
thyrotropin releasing hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8690305
NCBI chr22:51,075,814...51,079,852
Ensembl chr22:51,076,157...51,078,236
G
BMP4
bone morphogenetic protein 4
treatment
ISO
RGD
PMID:16332232
RGD:8699514
NCBI chr24:31,097,673...31,104,774
Ensembl chr24:31,097,538...31,101,225
G
IGF1
insulin like growth factor 1
ISO
protein:decreased expression:serum:
RGD
PMID:12002507
RGD:8548865
NCBI chr11:97,624,498...97,708,730
Ensembl chr11:97,631,189...97,707,308
G
PLAT
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1899364
NCBI chr 8:40,164,391...40,196,627
Ensembl chr 8:40,163,891...40,196,555
G
ADAM10
ADAM metallopeptidase domain 10
ISO
RGD
PMID:22489706
RGD:13703033
NCBI chr26:24,768,827...24,921,169
Ensembl chr26:24,768,915...24,919,009
G
AHR
aryl hydrocarbon receptor
ISO
protein:increased expression:T cell, neuron, brain cortex, hippocampus
RGD
PMID:27506546
RGD:405878081
NCBI chr21:40,778,198...40,826,491
Ensembl chr21:40,778,218...40,826,478
G
APP
amyloid beta precursor protein
treatment
ISO
RGD
PMID:29320530
RGD:13782048
NCBI chr 2:66,037,224...66,320,860
Ensembl chr 2:66,037,261...66,321,306
G
BAD
BCL2 associated agonist of cell death
treatment
ISO
RGD
PMID:24582457
RGD:13782254
NCBI chr 1:9,949,717...9,964,433
Ensembl chr 1:9,949,762...9,964,432
G
BDNF
brain derived neurotrophic factor
ISO
mRNA:increased expression:CA3 field of hippocampus, dentate gyrus
RGD
PMID:10925157
RGD:596936229
NCBI chr 1:37,386,825...37,451,380
Ensembl chr 1:37,449,593...37,450,336
G
CAPN1
calpain 1
severity
ISO
protein:increased expression:cytosol, plasma membrane
RGD
PMID:9469158 PMID:15307896
RGD:13792664 RGD:5509821
NCBI chr 1:9,014,087...9,050,389
Ensembl chr 1:9,014,084...9,049,804
G
CAPN2
calpain 2
severity
ISO
RGD
PMID:9469158 PMID:15307896
RGD:13792664 RGD:5509821
NCBI chr25:5,845,873...5,905,464
Ensembl chr25:5,846,298...5,905,402
G
CASP3
caspase 3
severity
ISO
protein:increased expression:cerebral cortex
RGD
PMID:15307896 PMID:27614125
RGD:329961568 RGD:5509821
NCBI chr 7:130,589,592...130,610,845
Ensembl chr 7:130,591,166...130,610,899
G
CASP8
caspase 8
disease_progression severity
ISO
RGD
PMID:12172380 PMID:15307896
RGD:5509821 RGD:632018
NCBI chr10:86,888,654...86,944,159
Ensembl chr10:86,916,527...86,943,829
G
CASP9
caspase 9
disease_progression severity
ISO
RGD
PMID:12172380 PMID:15307896
RGD:5509821 RGD:632018
NCBI chr20:116,772,819...116,798,402
Ensembl chr20:116,772,155...116,798,930
G
CD163
CD163 molecule
ISO
protein:increased expression:brain, macrophage (rat)
RGD
PMID:22583855
RGD:127285798
NCBI chr11:7,501,562...7,536,332
Ensembl chr11:7,501,150...7,536,295
G
CD8A
CD8 subunit alpha
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:31383034
RGD:124715446
NCBI chr14:18,878,013...18,885,183
Ensembl chr14:18,878,622...18,883,885
G
CIT
citron rho-interacting serine/threonine kinase
ISO
mRNA:decreased expression:cerebral cortex��(rat)
RGD
PMID:12503083
RGD:2317873
NCBI chr11:115,026,809...115,220,558
Ensembl chr11:115,025,045...115,219,356
G
CTNNB1
catenin beta 1
treatment
ISO
RGD
PMID:26296359
RGD:597538582
NCBI chr22:2,679,488...2,725,034
Ensembl chr22:2,684,022...2,723,949
G
CXCL10
C-X-C motif chemokine ligand 10
treatment
ISO
RGD
PMID:26435412
RGD:27095897
NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
G
CXCL12
C-X-C motif chemokine ligand 12
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr 9:40,005,580...40,020,513
Ensembl chr 9:40,011,439...40,020,494
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6
treatment
ISO
RGD
PMID:26068867
RGD:401901590
NCBI chr19:24,667,207...24,672,580
Ensembl chr19:24,667,282...24,671,513
G
DRD1
dopamine receptor D1
treatment
ISO
RGD
PMID:24047867
RGD:13506948
NCBI chr23:77,587,340...77,591,434
G
DRD2
dopamine receptor D2
treatment
ISO
RGD
PMID:24047867
RGD:13506948
NCBI chr 1:104,774,632...104,843,417
Ensembl chr 1:104,774,180...104,842,736
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
mRNA:decreased expression:cerebral cortex
RGD
PMID:31992337
RGD:329901857
NCBI chr 5:39,487,304...39,900,238
Ensembl chr 5:39,487,418...39,725,747
G
FUBP1
far upstream element binding protein 1
ISO
RGD
PMID:23797733
RGD:13673879
NCBI chr20:55,194,681...55,233,666
Ensembl chr20:55,194,743...55,230,277
G
GNAL
G protein subunit alpha L
ISO
RGD
PMID:29215295
RGD:13513923
NCBI chr18:69,508,254...69,699,628
Ensembl chr18:69,510,512...69,635,000
G
GRIA1
glutamate ionotropic receptor AMPA type subunit 1
ISO
protein:increased phosphorylation:central amygdaloid nucleus (rat)
RGD
PMID:30638118
RGD:405101698
NCBI chr23:55,944,128...56,265,748
Ensembl chr23:56,101,294...56,265,849
G
ICAM1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
ITGB1
integrin subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr 9:32,201,030...32,258,247
Ensembl chr 9:32,202,204...32,258,154
G
LAMA1
laminin subunit alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr18:65,996,233...66,162,510
G
LAMP2
lysosomal associated membrane protein 2
ISO
protein:increased expression:hippocampus:
RGD
PMID:28365875
RGD:13703062
G
LCN2
lipocalin 2
ISO
RGD
PMID:31539545
RGD:126781751
NCBI chr12:9,976,278...9,981,087
Ensembl chr12:9,976,614...9,980,870
G
LOC103244924
cyclin-G1
treatment
ISO
RGD
PMID:18612315 PMID:24398934
RGD:151356934 RGD:151356935
NCBI chr23:65,709,759...65,716,913
Ensembl chr23:65,709,786...65,714,711
G
MAPT
microtubule associated protein tau
treatment
ISO
RGD
PMID:25771151 PMID:26484783 PMID:26729399 PMID:28412141
RGD:13800902 RGD:13800909 RGD:13800912 RGD:13800917
NCBI chr16:59,894,400...60,020,723
Ensembl chr16:59,890,221...59,955,612
G
METTL14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
ISO
mRNA:decreased expression:cerebral cortex
RGD
PMID:31992337
RGD:329901857
NCBI chr 7:66,169,080...66,195,324
Ensembl chr 7:66,168,855...66,194,121
G
MMP2
matrix metallopeptidase 2
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr 5:41,264,382...41,291,657
Ensembl chr 5:41,264,354...41,291,004
G
MMP9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
G
MPO
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr16:35,120,194...35,130,851
Ensembl chr16:35,120,581...35,130,671
G
NCSTN
nicastrin
ISO
RGD
PMID:18240300
RGD:13801189
NCBI chr20:3,590,044...3,606,205
Ensembl chr20:3,590,725...3,606,066
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
protein:increased expression:brain:
RGD
PMID:30855558
RGD:26884463
NCBI chr10:62,789,647...62,825,651
Ensembl chr10:62,790,124...62,825,339
G
NGF
nerve growth factor
treatment
ISO
RGD
PMID:26285082
RGD:402463964
NCBI chr20:18,361,795...18,413,987
Ensembl chr20:18,413,108...18,413,833
G
NMNAT1
nicotinamide nucleotide adenylyltransferase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27822499
NCBI chr20:121,790,836...121,797,043
G
NOS2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
G
NOX1
NADPH oxidase 1
ISO
protein:increased expression:cerebral cortex
RGD
PMID:27614125
RGD:329961568
NCBI chr X:89,182,636...89,210,176
Ensembl chr X:89,183,264...89,209,298
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
protein:increased phosphorylation:amygdala mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:30638118 PMID:36637480
RGD:405101698 RGD:408364984
NCBI chr23:45,904,926...46,031,804
Ensembl chr23:45,904,873...46,031,125
G
NTRK2
neurotrophic receptor tyrosine kinase 2
ISO
mRNA:increased expression:dentate gyrus
RGD
PMID:10925157
RGD:596936229
NCBI chr12:95,477,612...95,836,734
Ensembl chr12:95,479,447...95,620,364
G
OCLN
occludin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593
NCBI chr 4:65,581,943...65,641,516
Ensembl chr 4:65,582,460...65,644,787
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15829224 PMID:28642177
NCBI chr25:3,350,798...3,405,040
G
PDE10A
phosphodiesterase 10A
ISO
RGD
PMID:29215295
RGD:13513923
NCBI chr13:93,012,027...93,684,349
Ensembl chr13:93,020,696...93,344,369
G
PDYN
prodynorphin
ISO
mRNA:increased expression:hippocampus
RGD
PMID:12626770
RGD:633616
NCBI chr 2:54,535,516...54,551,085
Ensembl chr 2:54,535,240...54,551,104
G
PHACTR1
phosphatase and actin regulator 1
treatment
ISO
RGD
PMID:36571365
RGD:401901253
NCBI chr17:58,859,456...59,440,969
Ensembl chr17:58,862,828...59,133,298
G
PPP3R1
protein phosphatase 3 regulatory subunit B, alpha
ISO
RGD
PMID:20713027
RGD:13830881
NCBI chr14:38,832,976...38,907,425
Ensembl chr14:38,832,809...38,905,321
G
PPP3R2
protein phosphatase 3 regulatory subunit B, beta
ISO
RGD
PMID:20713027
RGD:13830881
NCBI chr12:37,838,156...37,841,477
G
PSEN1
presenilin 1
ISO
RGD
PMID:18240300
RGD:13801189
NCBI chr24:50,394,310...50,476,521
Ensembl chr24:50,405,590...50,472,132
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25668593 PMID:28642177
NCBI chr 1:8,576,059...8,585,561
Ensembl chr 1:8,576,542...8,586,516
G
SOX2
SRY-box transcription factor 2
treatment
ISO
RGD
PMID:26296359
RGD:597538582
NCBI chr15:7,673,581...7,676,812
Ensembl chr15:7,674,867...7,675,826
G
TGFB1
transforming growth factor beta 1
treatment
ISO
RGD
PMID:28433746
RGD:14995478
NCBI chr 6:35,651,583...35,674,387
Ensembl chr 6:35,648,677...35,674,365
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28642177
G
TP53
tumor protein p53
treatment
ISO
RGD
PMID:27553877
RGD:14995939
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
G
UBE4B
ubiquitination factor E4B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27822499
NCBI chr20:121,597,775...121,744,986
G
WNT3A
Wnt family member 3A
treatment
ISO
RGD
PMID:26296359
RGD:597538582
NCBI chr25:1,664,316...1,675,006
Ensembl chr25:1,666,053...1,719,881
G
F7
coagulation factor VII
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20370756
NCBI chr 3:91,109,864...91,122,707
Ensembl chr 3:91,110,380...91,123,327
G
ABCC8
ATP binding cassette subfamily C member 8
treatment
ISO
RGD
PMID:18854840
RGD:2325137
NCBI chr 1:47,494,861...47,578,818
Ensembl chr 1:47,494,959...47,578,882
G
TP53
tumor protein p53
ISO
RGD
PMID:22977862
RGD:8547771
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
G
ADRB2
adrenoceptor beta 2
ISO
mRNA:increased expression:Vestibulocochlear nerve:
RGD
PMID:22178544
RGD:8548530
NCBI chr23:51,445,920...51,447,942
Ensembl chr23:51,446,154...51,447,401
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all